ATYR SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr PharmaFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In aTyr To Contact Him Directly To Discuss Their Options
Lost Money on aTyr Pharma, Inc.(ATYR)? Join Class Action Suit Seeking Recovery - Contact Levi & KorsinskyNEW YORK - October 24, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in aTyr Pharma, Inc. (
NASDAQ: ATYR) of a class action securities lawsuit.
Lost Money on aTyr Pharma, Inc.(ATYR)? Join Class Action Suit Seeking Recovery - Contact Levi & KorsinskySearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, Oct. 24, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against aTyr Pharma, Inc. (“aTyr” or “the Company”) (
NASDAQ: ATYR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in aTyr Pharma, Inc. of Class Action Lawsuit and Upcoming Deadlines - ATYRNEW YORK, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against aTyr Pharma, Inc. (“aTyr” or the “Company”) (
NASDAQ: ATYR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
Deadline Alert: aTyr Pharma Inc. (ATYR) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
Glancy Prongay & Murray LLP reminds investors of the upcoming December 8, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired aTyr Pharma Inc. (“aTyr” or the “Company”) (
NASDAQ: ATYR) common stock between January 16, 2025 and September 12, 2025, inclusive (the “Class Period”).
Lost Money on aTyr Pharma, Inc. (ATYR)? Join Class Action Suit Seeking Recovery - Contact Levi & KorsinskySearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Lost Money on aTyr Pharma, Inc. (ATYR)? Join Class Action Suit Seeking Recovery - Contact Levi & KorsinskyNEW YORK - October 23, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in aTyr Pharma, Inc. (
NASDAQ: ATYR) of a class action securities lawsuit.
Bragar Eagel & Squire, P.C. Reminds Investors of aTyr, Marex, Cepton, and MoonLake to Contact the Firm About their Rights in Filed Class Action LawsuitsNEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of aTyr Pharma, Inc. (
NASDAQ:ATYR), Marex Group PLC (
NASDAQ:MRX), Cepton, Inc. (
NASDAQ:CPTN), and MoonLake Immunotherapeutics (
NASDAQ:MLTX). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
Deadline Approaching: aTyr Pharma Inc. (ATYR) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith
Law Offices of Howard G. Smith reminds investors of the upcoming December 8, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased aTyr Pharma Inc. (“aTyr” or the “Company”) (
NASDAQ: ATYR) common stock between January 16, 2025 and September 12, 2025, inclusive (the “Class Period”).
Shareholders That Lost Money on aTyr Pharma, Inc. (ATYR) Urged to Join Class Action - Contact Levi & Korsinsky to Learn MoreSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Shareholders That Lost Money on aTyr Pharma, Inc. (ATYR) Urged to Join Class Action - Contact Levi & Korsinsky to Learn MoreNEW YORK - October 22, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in aTyr Pharma, Inc. (
NASDAQ: ATYR) of a class action securities lawsuit.
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 8, 2025 in aTyr Pharma, Inc. Lawsuit - ATYRSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 8, 2025 in aTyr Pharma, Inc. Lawsuit - ATYRNEW YORK - October 21, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in aTyr Pharma, Inc. (
NASDAQ: ATYR) of a class action securities lawsuit.
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages aTyr Pharma Inc. (ATYR) Shareholders To Inquire About Securities Fraud Class Action
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired aTyr Pharma Inc. (“aTyr” or the “Company”) (
NASDAQ: ATYR) common stock between January 16, 2025 and September 12, 2025, inclusive (the “Class Period”). aTyr investors have until December 8, 2025 to file a lead plaintiff motion.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in aTyr Pharma, Inc. of Class Action Lawsuit and Upcoming Deadlines – ATYRNEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against aTyr Pharma, Inc. (“aTyr” or the “Company”) (
NASDAQ: ATYR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
Class Action Filed Against aTyr Pharma, Inc. (ATYR) - December 8, 2025 Deadline to Join - Contact Levi & KorsinskySearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Class Action Filed Against aTyr Pharma, Inc. (ATYR) - December 8, 2025 Deadline to Join - Contact Levi & KorsinskyNEW YORK - October 20, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in aTyr Pharma, Inc. (
NASDAQ: ATYR) of a class action securities lawsuit.
Law Offices of Frank R. Cruz Encourages aTyr Pharma Inc. (ATYR) Shareholders To Inquire About Securities Fraud Class Action
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of shareholders who purchased aTyr Pharma Inc. (“aTyr” or the “Company”) (
NASDAQ: ATYR) common stock between January 16, 2025 and September 12, 2025, inclusive (the “Class Period”). aTyr investors have until December 8, 2025 to file a lead plaintiff motion.
Law Offices of Howard G. Smith Encourages aTyr Pharma Inc. (ATYR) Shareholders To Inquire About Securities Fraud Class Action
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased aTyr Pharma Inc. (“aTyr” or the “Company”) (
NASDAQ: ATYR) common stock between January 16, 2025 and September 12, 2025, inclusive (the “Class Period”). aTyr investors have until December 8, 2025 to file a lead plaintiff motion.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in aTyr Pharma, Inc. of Class Action Lawsuit and Upcoming Deadlines - ATYRNEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against aTyr Pharma, Inc. (“aTyr” or the “Company”) (
NASDAQ: ATYR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
Levi & Korsinsky Notifies Shareholders of aTyr Pharma, Inc. (ATYR) of a Class Action Lawsuit and an Upcoming DeadlineSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Levi & Korsinsky Notifies Shareholders of aTyr Pharma, Inc. (ATYR) of a Class Action Lawsuit and an Upcoming DeadlineNEW YORK - October 17, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in aTyr Pharma, Inc. (
NASDAQ: ATYR) of a class action securities lawsuit.
Securities Fraud Investigation Into aTyr Pharma Inc. (ATYR) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of aTyr Pharma Inc. (“aTyr” or the “Company”) (
NASDAQ: ATYR) investors concerning the Company’s possible violations of the federal securities laws.
aTyr Pharma Inc. (ATYR) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Law Offices of Howard G. Smith announces an investigation on behalf of aTyr Pharma Inc. (“aTyr” or the “Company”) (
NASDAQ: ATYR) investors concerning the Company’s possible violations of federal securities laws.
